Skip to content

EyePoint, Inc. EYPT Additional Paid-In Capital

Additional Paid-In Capital at other companies

Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.83B+49.6%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$1.73B+15.6%
Bausch + Lomb logo
Bausch + LombBLCO
$8.58B+1.6%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$6.08B+4.7%
Merck & Co. logo
Merck & Co.MRK
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's additional paid-in capital?
EyePoint, Inc. (EYPT) reported additional paid-in capital of $1.42B in Q1 2026.
How has EyePoint, Inc. 's additional paid-in capital changed year-over-year?
EyePoint, Inc. 's additional paid-in capital increased by 16.8% year-over-year, from $1.22B to $1.42B.
What is the long-term trend for EyePoint, Inc. 's additional paid-in capital?
Over 5 years (2020 to 2025), EyePoint, Inc. 's additional paid-in capital has grown at a 21.7% compound annual growth rate (CAGR), from $528.36M to $1.41B.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.